Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Methotrexate | 1 | uM | 4 | 5000.00 | 3240.08 | 2542.00 | 5514.25 | 0.4610 | -0.2712 |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5540.00 | 5514.25 | 1.0047 | 1.0122 | |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5549.00 | 5514.25 | 1.0063 | 1.0164 | |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5295.00 | 5514.25 | 0.9602 | 0.8970 | |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5038.00 | 5514.25 | 0.9136 | 0.7778 | |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5172.00 | 5514.25 | 0.9379 | 0.8397 | |
SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 5000.00 | 3240.08 | 5223.00 | 5514.25 | 0.9472 | 0.8634 |
SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5257.00 | 5514.25 | 0.9534 | 0.8792 |
SK-BR-3 | Omipalisib | 1 | uM | 4 | 5000.00 | 3240.08 | 1964.00 | 5514.25 | 0.3562 | -0.4793 |
SK-BR-3 | Methotrexate | 10 | uM | 4 | 5000.00 | 3240.08 | 2694.00 | 5514.25 | 0.4886 | -0.2138 |
SK-BR-3 | Palbociclib | 1 | uM | 4 | 5000.00 | 3240.08 | 3849.00 | 5514.25 | 0.6980 | 0.2517 |
SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 2864.00 | 5514.25 | 0.5194 | -0.1486 |
SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 5000.00 | 3240.08 | 4770.00 | 5514.25 | 0.8650 | 0.6556 |
SK-BR-3 | Methotrexate | 0.1 | uM | 4 | 5000.00 | 3240.08 | 3285.00 | 5514.25 | 0.5957 | 0.0181 |
SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 2086.00 | 5514.25 | 0.3783 | -0.4367 |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5712.00 | 5514.25 | 1.0359 | 1.0940 | |
SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 4035.00 | 5514.25 | 0.7317 | 0.3311 |
SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 5000.00 | 3240.08 | 3249.00 | 5514.25 | 0.5892 | 0.0036 |
SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5459.00 | 5514.25 | 0.9900 | 0.9739 | |
SK-BR-3 | Omipalisib | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 3712.00 | 5514.25 | 0.6732 | 0.1939 |
SK-BR-3 | Taxol | 0.1 | uM | 4 | 5000.00 | 3240.08 | 2509.00 | 5514.25 | 0.4550 | -0.2835 |
SK-BR-3 | Taxol | 0.001 | uM | 4 | 5000.00 | 3240.08 | 5637.00 | 5514.25 | 1.0223 | 1.0582 |
SK-BR-3 | Palbociclib | 3.1623 | uM | 4 | 5000.00 | 3240.08 | 3912.00 | 5514.25 | 0.7094 | 0.2785 |
SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 4529.00 | 5514.25 | 0.8213 | 0.5474 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 5000.00 | 3240.08 | 3335.00 | 5514.25 | 0.6048 | 0.0384 |